<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04106089</url>
  </required_header>
  <id_info>
    <org_study_id>18-015878</org_study_id>
    <secondary_id>DCHS20PPR006</secondary_id>
    <nct_id>NCT04106089</nct_id>
  </id_info>
  <brief_title>Sleep in Pediatric HSCT</brief_title>
  <official_title>Sleep in Pediatric Hematopoietic Stem Cell Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rutgers University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NJ Dept of Health Commission on Cancer Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through an aggregated N=1 randomized controlled design (each patient will serve as their own
      control, with the 5-day intervention period determined by randomization), the current study
      will test the acceptability, feasibility, and impact on sleep and supportive care engagement
      of protecting one 6-hour window for nighttime sleep (intervention) relative to regular vitals
      checks (observation only periods) during Hematopoietic Stem Cell Transplant (HSCT) recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Context: Patients undergoing treatment for cancer face disease, treatment, and environmental
      obstacles to sufficient, sound sleep. Hospitalizations can further worsen sleep quality and
      quantity due to overnight vitals checks, medication administration, blood draws, and
      environmental noise and light. For patients undergoing hematopoietic stem cell transplant
      (HSCT), the risk for poor sleep is especially high due to protracted hospitalization,
      frequent vitals checks resulting in multiple night awakenings, and high symptom burden
      peaking approximately 10 days post-transplant.

      Objectives:

      Primary: Test the acceptability and feasibility of protecting one 6-hour window for nighttime
      sleep (intervention) relative to regular vitals checks (observation only periods) during HSCT
      recovery.

      Secondary: Assess the effect of one 6-hour window for nighttime sleep on subject sleep and
      engagement in supportive care on the oncology unit.

      Study Design:

      Aggregated N=1 randomized controlled design. All participants will undergo a 5 day
      observation and then be randomized to receive the 5 day intervention (extended vitals checks)
      during either nights of days +5-+9 or days +10-+14.

      Setting/Participants:

      Inpatients on the HSCT Unit at the Children's Hospital of Philadelphia (CHOP)

      Study Interventions and Measures:

      Interventionâ€”increasing time between vitals checks from every 4 hours to one 6-hour period at
      night.

      Subjects will wear an actigraph for the duration of the study, complete a daily sleep diary,
      and complete self- and parent-proxy psychosocial measures (symptom burden, health related
      quality of life, sleep) and acceptability. Medical record review will also be conducted to
      assess vitals check frequency.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 18, 2019</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Aggregated N of 1 design (ABA or AAB)</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>actigraphy scoring will be conducted by study staff blind to patient study arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient acceptability questionnaire</measure>
    <time_frame>15 days after transplant</time_frame>
    <description>Brief questionnaire evaluating the patient's acceptability of adjusting vitals checks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parent acceptability questionnaire</measure>
    <time_frame>15 days after transplant</time_frame>
    <description>Brief questionnaire evaluating the parent's acceptability of adjusting vitals checks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nurse acceptability questionnaire</measure>
    <time_frame>15 days after transplant</time_frame>
    <description>Brief questionnaire evaluating the nurse's acceptability of adjusting vitals checks.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related quality of life (HRQL)</measure>
    <time_frame>Baseline visit (1-2 days before transplant), 5 days after transplant, 10 days after transplant, and 15 days after transplant</time_frame>
    <description>Using the Pediatric Quality of Life Inventory - Stem Cell Transplant (SCT) module</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Actigraphy sleep efficiency</measure>
    <time_frame>Day of the transplant through 15 days after the transplant</time_frame>
    <description>Sleep efficiency is the percentage of time spent asleep, while in bed. It is calculated by dividing the time spent asleep, by the total amount of time in bed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actigraphy total sleep time</measure>
    <time_frame>Day of the transplant through 15 days after the transplant</time_frame>
    <description>This will measure the total amount of time the subject sleeps.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actigraphy number of awakenings</measure>
    <time_frame>Day of the transplant through 15 days after the transplant</time_frame>
    <description>This measure the number of times the subject awakens from rest, whether sleep or a nap.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sleep</condition>
  <condition>Stem Cell Transplant Complications</condition>
  <arm_group>
    <arm_group_label>Observation-Intervention-Observation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 days of observation, 5 days of extended vitals check, 5 days returning to regular vitals checks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation-Observation-Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 days of observation, 5 more days of observation, 5 days of extended vitals check</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Extended time between vitals check</intervention_name>
    <description>Participants will have 6 hours protected sleep time (vitals checks moved from every 4 to every 6 hours)</description>
    <arm_group_label>Observation-Intervention-Observation</arm_group_label>
    <arm_group_label>Observation-Observation-Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males or females age 8 to 21 years.

          2. Undergoing HSCT at The Children's Hospital of Philadelphia

          3. Parent/guardian permission (informed consent) and if appropriate, child assent.

        Exclusion Criteria:

          1. History of developmental delays given the relationship to sleep/wake patterns

          2. Sleep disorder diagnosis as documented in the medical record

          3. Cognitive delays that impact the ability to complete study measures

          4. Not proficient in English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lamia Barakat, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHOP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Walter LM, Nixon GM, Davey MJ, Downie PA, Horne RS. Sleep and fatigue in pediatric oncology: A review of the literature. Sleep Med Rev. 2015 Dec;24:71-82. doi: 10.1016/j.smrv.2015.01.001. Epub 2015 Jan 13. Review.</citation>
    <PMID>25679070</PMID>
  </reference>
  <reference>
    <citation>Lee S, Narendran G, Tomfohr-Madsen L, Schulte F. A systematic review of sleep in hospitalized pediatric cancer patients. Psychooncology. 2017 Aug;26(8):1059-1069. doi: 10.1002/pon.4149. Epub 2016 May 5. Review.</citation>
    <PMID>27147507</PMID>
  </reference>
  <reference>
    <citation>Dandoy CE, Coleman KM, Petiniot L, et al. Prospective pilot study evaluating sleep disruption in children and young adults undergoing stem cell transplantation. Biol Blood Marrow Transplant. 2015;21(2):S216.</citation>
  </reference>
  <reference>
    <citation>Felder-Puig R, di Gallo A, Waldenmair M, Norden P, Winter A, Gadner H, Topf R. Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study. Bone Marrow Transplant. 2006 Jul;38(2):119-26.</citation>
    <PMID>16820782</PMID>
  </reference>
  <reference>
    <citation>Moldofsky H. Sleep and the immune system. Int J Immunopharmacol. 1995 Aug;17(8):649-54. Review.</citation>
    <PMID>8847159</PMID>
  </reference>
  <reference>
    <citation>Everson CA. Sustained sleep deprivation impairs host defense. Am J Physiol. 1993 Nov;265(5 Pt 2):R1148-54.</citation>
    <PMID>8238617</PMID>
  </reference>
  <reference>
    <citation>Hui L, Hua F, Diandong H, Hong Y. Effects of sleep and sleep deprivation on immunoglobulins and complement in humans. Brain Behav Immun. 2007 Mar;21(3):308-10. Epub 2006 Oct 27. Erratum in: Brain Behav Immun. 2010 May;24(4):678-9.</citation>
    <PMID>17070668</PMID>
  </reference>
  <reference>
    <citation>GÃ¶tte M, Kesting S, Winter C, Rosenbaum D, Boos J. Experience of barriers and motivations for physical activities and exercise during treatment of pediatric patients with cancer. Pediatr Blood Cancer. 2014 Sep;61(9):1632-7. doi: 10.1002/pbc.25071. Epub 2014 Apr 17.</citation>
    <PMID>24753116</PMID>
  </reference>
  <reference>
    <citation>Rosen GM, Shor AC, Geller TJ. Sleep in children with cancer. Curr Opin Pediatr. 2008 Dec;20(6):676-81. Review.</citation>
    <PMID>19023918</PMID>
  </reference>
  <reference>
    <citation>Hart CN, Palermo TM, Rosen CL. Health-related quality of life among children presenting to a pediatric sleep disorders clinic. Behav Sleep Med. 2005;3(1):4-17.</citation>
    <PMID>15639754</PMID>
  </reference>
  <reference>
    <citation>Buckhalt JA, El-Sheikh M, Keller P. Children's sleep and cognitive functioning: race and socioeconomic status as moderators of effects. Child Dev. 2007 Jan-Feb;78(1):213-31.</citation>
    <PMID>17328701</PMID>
  </reference>
  <reference>
    <citation>Lavigne JV, Arend R, Rosenbaum D, Smith A, Weissbluth M, Binns HJ, Christoffel KK. Sleep and behavior problems among preschoolers. J Dev Behav Pediatr. 1999 Jun;20(3):164-9.</citation>
    <PMID>10393073</PMID>
  </reference>
  <reference>
    <citation>Smaldone A, Honig JC, Byrne MW. Sleepless in America: inadequate sleep and relationships to health and well-being of our nation's children. Pediatrics. 2007 Feb;119 Suppl 1:S29-37.</citation>
    <PMID>17272582</PMID>
  </reference>
  <reference>
    <citation>Meltzer LJ, Mindell JA. Relationship between child sleep disturbances and maternal sleep, mood, and parenting stress: a pilot study. J Fam Psychol. 2007 Mar;21(1):67-73.</citation>
    <PMID>17371111</PMID>
  </reference>
  <reference>
    <citation>Moldofsky H. Sleep and pain. Sleep Med Rev. 2001 Oct;5(5):385-396.</citation>
    <PMID>12531004</PMID>
  </reference>
  <reference>
    <citation>Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl). 2001 Dec;10(4):245-55. Review.</citation>
    <PMID>11806675</PMID>
  </reference>
  <reference>
    <citation>Lewin DS, Dahl RE. Importance of sleep in the management of pediatric pain. J Dev Behav Pediatr. 1999 Aug;20(4):244-52. Review.</citation>
    <PMID>10475599</PMID>
  </reference>
  <reference>
    <citation>Collins JJ, Byrnes ME, Dunkel IJ, Lapin J, Nadel T, Thaler HT, Polyak T, Rapkin B, Portenoy RK. The measurement of symptoms in children with cancer. J Pain Symptom Manage. 2000 May;19(5):363-77.</citation>
    <PMID>10869877</PMID>
  </reference>
  <reference>
    <citation>Hockenberry MJ, Hooke MC, Gregurich M, McCarthy K, Sambuco G, Krull K. Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide. Oncol Nurs Forum. 2010 Jan;37(1):E16-27. doi: 10.1188/10.ONF.E16-E27.</citation>
    <PMID>20044328</PMID>
  </reference>
  <reference>
    <citation>Phipps S, Dunavant M, Garvie PA, Lensing S, Rai SN. Acute health-related quality of life in children undergoing stem cell transplant: I. Descriptive outcomes. Bone Marrow Transplant. 2002 Mar;29(5):425-34.</citation>
    <PMID>11919733</PMID>
  </reference>
  <reference>
    <citation>Rischer J, Scherwath A, Zander AR, Koch U, Schulz-Kindermann F. Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 Jul;44(2):121-8. doi: 10.1038/bmt.2008.430. Epub 2009 Jan 19.</citation>
    <PMID>19151796</PMID>
  </reference>
  <reference>
    <citation>Rentscher K, Broman A, Coe C, et al. Biomarkers associated with risk and recovery in cancer patients after hematopoietic stem cell transplantation. Brain Behav Immun. 2017;66:e41-e42.</citation>
  </reference>
  <reference>
    <citation>Ekti Genc R, Conk Z. Impact of effective nursing interventions to the fatigue syndrome in children who receive chemotherapy. Cancer Nurs. 2008 Jul-Aug;31(4):312-7. doi: 10.1097/01.NCC.0000305740.18711.c6.</citation>
    <PMID>18600119</PMID>
  </reference>
  <reference>
    <citation>Hinds PS, Hockenberry M, Rai SN, Zhang L, Razzouk BI, McCarthy K, Cremer L, Rodriguez-Galindo C. Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol Nurs Forum. 2007 Mar;34(2):393-402.</citation>
    <PMID>17573303</PMID>
  </reference>
  <reference>
    <citation>Mandrell BN, Pritchard M, Browne E, Clifton S, Crabtree VM. A pilot study to examine sleep in pediatric brain tumor patients hospitalized for high dose chemotherapy. Associated Professional Sleep Socities; 2013; Baltimore, MD.</citation>
  </reference>
  <reference>
    <citation>Lawitschka A, GÃ¼clÃ¼ ED, Varni JW, Putz M, Wolff D, Pavletic S, Greinix H, Peters C, Felder-Puig R. Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study. Bone Marrow Transplant. 2014 Aug;49(8):1093-7. doi: 10.1038/bmt.2014.96. Epub 2014 May 12.</citation>
    <PMID>24820217</PMID>
  </reference>
  <reference>
    <citation>Forrest CB, Meltzer LJ, Marcus CL, de la Motte A, Kratchman A, Buysse DJ, Pilkonis PA, Becker BD, Bevans KB. Development and validation of the PROMIS Pediatric Sleep Disturbance and Sleep-Related Impairment item banks. Sleep. 2018 Jun 1;41(6). doi: 10.1093/sleep/zsy054.</citation>
    <PMID>29546286</PMID>
  </reference>
  <reference>
    <citation>Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. Oxford university press; 2003.</citation>
  </reference>
  <reference>
    <citation>Cushing CC, Walters RW, Hoffman L. Aggregated N-of-1 randomized controlled trials: modern data analytics applied to a clinically valid method of intervention effectiveness. J Pediatr Psychol. 2014 Mar;39(2):138-50. doi: 10.1093/jpepsy/jst083. Epub 2013 Nov 26.</citation>
    <PMID>24284134</PMID>
  </reference>
  <reference>
    <citation>Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr;31(2):180-91. doi: 10.1002/nur.20247. Review.</citation>
    <PMID>18183564</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

